New indication added for selection of patients for amyloid-directed therapiesQuantitative image analysis addedPrevious limitations of use removed BOSTON, July 1, 2025 /PRNewswire/ -- Life Molecular ...

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) has received an average recommendation of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat reports. One ...

Equities researchers at Lifesci Capital issued their Q2 2025 EPS estimates for Cogent Biosciences in a research report issued to clients and investors on Monday, June 30th. Lifesci Capital analyst S.

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

RGN-259 is a thymosin beta-4–based eye drop designed to rival Dompé’s Oxervate, the only FDA-approved prescription eye drop ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.